Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention

I. Oyagüez,Carmen Suárez,Jose Lopez-Sendon,José Ramón González-Juanatey,Fernando de Andrés-Nogales,Jorge Suárez,Carlos Polanco,Javier Soto

Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention

2019

I. Oyagüez
Carmen Suárez
Jose Lopez-Sendon
José Ramón González-Juanatey
Fernando de Andrés-Nogales
Jorge Suárez
Carlos Polanco
Javier Soto

Objective Our objective was to assess the cost effectiveness of apixaban versus edoxaban in the prevention of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) in Spain.

Keywords:

Edoxaban
Stroke
Cost-effectiveness analysis
Apixaban
Cardiology
Atrial fibrillation
Medicine
Internal medicine
cost effectiveness
Cohort
Emergency medicine
Population

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations